Re’equil Oxybenzone & OMC Free Sunscreen SPF 50+
Sunscreen
An affordable SPF 50+ sunscreen positioned for oily and acne-prone skin, with a lightweight lotion format and no oxybenzone or OMC. A practical everyday option for people prioritizing high-SPF sun protection without a heavy sunscreen feel.
Heranvi's editorial assessment based on completeness, evidence, review confidence, freshness and trust signals. Not a universal scientific rating.
Best For
Best suited to oily or acne-prone skin looking for an everyday high-SPF sunscreen with a lightweight finish.
- Oily / Acne-Prone Skin
Addresses
- Sun Damage / UV Exposure
Pros & Cons
Pros
- SPF 50+ broad-spectrum positioning
- Formulated without oxybenzone or OMC
- Positioned as non-comedogenic for oily and acne-prone skin
- Relatively accessible MRP of ₹395 for 50 g
- Full ingredient list is publicly available
Cons
- Contains fragrance
- Manufacturer efficacy and tolerability claims are not independent clinical evidence
- Individual skin tolerability can vary
- Heranvi has not conducted hands-on or laboratory testing of this product
How We Evaluated This
Heranvi evaluated this product through desk research using the manufacturer's current product information and published ingredient list, together with independent dermatology guidance and peer-reviewed research on sunscreen use. Heranvi has not conducted hands-on, consumer-panel, or laboratory testing of this product.
Last reviewed September 19, 2026
Evidence
American Academy of Dermatology (AAD)
The American Academy of Dermatology recommends choosing sunscreen with SPF 30 or higher, broad-spectrum UVA/UVB protection, and water resistance. For acne-prone or oily skin, it recommends looking for products labelled non-comedogenic or “won’t clog pores.” This source provides general sunscreen-selection guidance and does not evaluate or endorse the specific Heranvi product.
View sourceThe Lancet — Green et al. (1999)
Randomized controlled trial involving 1,621 adults in Queensland, Australia, comparing daily SPF 15+ sunscreen application with discretionary sunscreen use over approximately 4.5 years. Daily sunscreen use was associated with a significantly lower incidence of squamous-cell carcinoma tumors, while no significant preventive effect was demonstrated for basal-cell carcinoma. This evidence supports regular sunscreen use generally and does not evaluate or endorse any specific Heranvi product.
View sourceRe’equil India
Official manufacturer information for Re’equil Oxybenzone & OMC Free Sunscreen. The page identifies the product as a 50 g broad-spectrum SPF 50+ sunscreen formulated without oxybenzone or OMC and positioned for oily, acne-prone skin. It provides the product's ingredient list and states that the formulation contains fragrance. This record documents manufacturer-provided product specifications and claims; it is not independent evidence of efficacy, tolerability, acne prevention, or superiority over other sunscreens.
View source
